title: Increased time varying heart rate and cardiovascular risk in hypertension: benefit of selective I((f)) channel inhibitor?
authors.forename: Sverre E
authors.initials: SE
authors.lastname: Kjeldsen
authors.forename: Thomas
authors.initials: T
authors.lastname: Hedner
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Narkiewicz
authors.forename: Suzanne
authors.initials: S
authors.lastname: Oparil
mesh_terms: D001552:Benzazepines / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006321:Heart / Q000187:drug effects* / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D007473:Ion Channels / Q000037:antagonists & inhibitors; D000077550:Ivabradine; D012306:Risk; D013610:Tachycardia / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D001552:Benzazepines; D007473:Ion Channels; D000077550:Ivabradine